Navigation Links
Lilly Reports Fourth-Quarter and Full-Year 2008 Results
Date:1/29/2009

taneous coronary intervention (PCI). The CHMP positive opinion is now referred for final action to the European Commission.

-- Olanzapine long-acting injection was approved by the European Commission under the trade name Zypadhera(TM).

-- The company received a complete response letter from the FDA for olanzapine long-acting injection for acute and maintenance treatment of schizophrenia in adults. Lilly is continuing to work with the agency on the new drug application (NDA). The FDA does not require any additional clinical trials for the continued review of the NDA. Per the agency's request, the company is preparing a proposed Risk Evaluation and Mitigation Strategy (REMS), which will be submitted in the near future.

-- The company withdrew its supplemental New Drug Application (sNDA) from the FDA for Cymbalta for the management of chronic pain. The company plans to resubmit the application in the first half of 2009, adding data from a recently completed study in chronic osteoarthritis pain of the knee.

-- The company entered into a license and supply arrangement with United Therapeutics Corporation related to the U.S. commercialization rights for the pulmonary arterial hypertension (PAH) indication of tadalafil. The indication is currently under review by the FDA.

-- The Federal Supreme Court (BGH) in Germany re-established the company's Zyprexa patent that had been declared invalid in 2007 by the German Federal Patent Court. As a result of this ruling, generic olanzapine has been withdrawn from the German market.

Fourth-Quarter Significant Items Affecting Reported Net Income (Loss)

The reported results for the fourth quarters of 2008 and 2007 were affected by significant items totaling $4.38 and $.12 per share, respectively, which are summarized below and in the table that follows:

2008

-- The company recognized pr
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... The New Jersey Chapter of the ... two administrators from Windsor Healthcare Communities, a leading ... Jersey, to two key leadership roles at this ... administrator for Abingdon Care & Rehabilitation Center of ... administrator of Canterbury Care & Rehabilitation Center at ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Tickets are ... show and Denver tradition since 1973. The 2015 Spring ... of Showtime on Ice. On April 24 in partnership ... event and opening night tribute to the Pat Bowlen ... A portion of the opening event proceeds will go ...
(Date:3/31/2015)... March 31, 2015 Indiana Fiber ... Service Provider, announces that Joink, LLC selected IFN ... According to Cory Childs, IFN Enterprise Sales ... specifically targeted at Internet Service Providers, Telecom companies, ... service provides Joink with diverse protected transport from ...
(Date:3/31/2015)... March 31, 2015 Rising rates of ... forced researchers and surgeons to better analyze and investigate ... used for repair. A recent study published ... systematic review of 1,016 young, very active patients to ... , “This is the first review to examine ...
(Date:3/31/2015)... Azilen Technologies adds yet another feather ... Company’ award at GESIA 2015. The firm earned this ... Award GESIA 2015. This marks Azilen’s second triumph at ... previously won the ‘Best Product Innovation’ award at GESIA ... development, enterprise mobility solutions and open source technologies. With ...
Breaking Medicine News(10 mins):Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 3Health News:ACL Failure Risks Increased in Young Patients Using Allografts 2Health News:Azilen Technologies Receives ‘Best Product Development Company’ Award at GESIA 2015 2
... youngsters lose weight by concentrating on the way they look, ... them// gorge even more, according to a recent study. ... to change their eating habits than those who are happy ... that getting children of all shapes and sizes to think ...
... has revealed that the risk of atherosclerosis in diabetics ... is characterized by// thickening and hardening of artery walls. ... atherosclerosis. ,This study, conducted by researchers at ... a decrease in the risk of developing atherosclerosis in ...
... Incidences of breast cancer are twice as much within a ... month due to this disease. Scientists have issued a warning// ... may be the reason for this escalation of breast cancer. ... which have very similar structures as compared to the female ...
... of suspected chikungunya fever in Kerala will not affect the ... Tuesday. ,"As the World Health Organisation (WHO) has ... here is not chikungunya, things have cheered up. There have ... booked to travel to Kerala," Balakrishnan told reporters here. ...
... claimed yet another life, taking the death toll in the ... into city hospitals// with the mosquito-borne viral disease showing no ... is now 1,631, with 83 new patients admitted in the ... of the virus is 55-year-old Pritam of Faridabad town close ...
... yoga, pranayama and meditation besides controlled breathing techniques to ... Art of Living Foundation//. ,Encouraged by the efficacy ... chikungunya, a mosquito-borne disease that can prove fatal, the ... India to cater to people suffering from the disease. ...
Cached Medicine News:Health News:Obese Kids Unmotivated byWeight Loss campaigns 2Health News:One More Victim Succumbs to Dengue in Delhi 2Health News:Yoga and Meditation May be Helpful to Combat Chikungunya 2
(Date:3/31/2015)... HOUSTON , March 31, 2015 ... at the American Association of Orthodontics 2015 Annual ... leading orthodontists present scientific lectures on AcceleDent ® ... the leader in accelerated orthodontics, AcceleDent is a ... orthodontic treatment by as much as 50 percent ...
(Date:3/31/2015)... ALTO, Calif. , March 31, 2015  Frequentz ... visibility, has released a white paper to help the ... the 2013 Drug Supply Chain Security Act (DSCSA). The ... various stages of the GS1 EPCIS Standard(s) ... detailed outlook on the product tracing requirements that need ...
(Date:3/31/2015)... 31, 2015  Mark Farrah Associates (MFA), ... (MA) plans in their recent analysis brief.  According ... enrolled in Medicare Advantage plans as of March ... members year-over-year.  54.3 million people are eligible for ... Medicaid Services (CMS), with an unpenetrated market of ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: